Atherectomy Market By Product Type (Directional Atherectomy Systems, Rotational Atherectomy Systems, Orbital Atherectomy Systems, Laser Atherectomy Systems), By Application (Cardiovascular Disease {Coronary Artery Disease}, Peripheral Vascular Disease {Lower Extremity Disease, Upper Extremity Disease}, Neurovascular Disease), By Technology (Mechanical Atherectomy, Laser-Based Atherectomy, Ultrasound-Based Atherectomy), By Mode of Operation (Automated, Manual), and By End-User (Hospitals, Ambulatory Surgical Centers {ASCs, Specialty Clinics, Others }, Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Industry Outlook

The Atherectomy Market accounted for USD 1.05 Billion in 2024 and is expected to reach USD 2.4 Billion by 2035, growing at a CAGR of around 7.8% between 2025 and 2035. The Atherectomy Market can be defined as the area of specialization for firms that provide and produce these medical tools called atherectomy devices, which are employed to scrape away plaque in blood vessels. PAD, CAD, and other conditions that result in constriction of blood vessels so that blood cannot circulate freely are among the diseases these devices seek to address.

Atherectomy procedures assist in decreasing the number of more invasive operations, less invasive than bypass surgeries, and are used together with other interventional procedures, including angioplasty. The market is fueled by an aging population, a rise in the prevalence of lifestyle diseases such as diabetes and hypertension, and an evolution in the technology used to perform minimally invasive procedures. The major stakeholders are the device manufacturers, hospitals, outpatient clinics, and the end users, such as patients. Looking to the future, there is every indication that development in the Atherectomy Market will progress due to novel laser and rotational atherectomy systems.

Report Scope:

Market Dynamics

Rising cases of peripheral artery disease (PAD) and coronary artery disease (CAD) drive the demand for atherectomy devices.

The increasing numbers of occurrences of peripheral artery disease and coronary artery disease further boost the Atherectomy Market with increasing demands for atherectomy devices. PAD is a disease in which the arteries in the legs become narrowed, while CAD involves arteries providing blood to the heart. Both lead to plaque formation and closure of blood vessels It increases the symptoms such as heart attacks, stroke, and even the necessity for limb amputations. Such conditions are more prominent today because of factors like a growing geriatric populace, poor physiological activity, unhealthy eating and drinking habits, and the steadily rising incidence of such diseases as diabetes, and hypertension.

Data regarding vascular diseases available from governmental sources proves the necessity of proper treatments. Initiating awareness and proactive diagnosis of the diseases requiring Atherectomy therapies are making more patients seek treatments. These types of devices afford significant and selective plaque control while offering minimal tissue destruction, which remains highly recommended by caregivers. Increased cardiovascular diseases and subsequent government campaigns for vascular difficulties will further boost the Atherectomy Market. There is an increased awareness of atherectomy devices created by online health platforms and the use of various digital tools and patient portals.

The growing geriatric population, which is more prone to cardiovascular conditions, contributes to market growth.

A large number of geriatric patients is expected to have a significant impact on the growth of the Atherectomy Market. PAD and CAD are considered age-related diseases and their occurrence becomes progressively higher as one progressively ages. It acquires age-related variations that increase the probability of the formation of plaques in blood vessels in elderly people. This generates a continuing demand for treatments including atherectomy to physically clear blockages and open up blood vessels. Due to growing rates of life expectancy across the world, the elderly population continues to grow, which will subsequently mean higher requirements for more Atherectomy therapy procedures.

Most elderly patients present with multiple co-morbidities, for example, diabetes, hypertension, and obesity, which are risk factors for cardiovascular diseases. Procedures such as atherectomy are on the upward trend, as patients prefer less invasive procedures with shorter recovery times and minimum exposure to complications that are common with surgeries. These age-related cardiovascular disorders are sought to be addressed through the help of atherectomy devices by a growing number of healthcare options. As the number of elderly people increases around the globe, the Atherectomy Market is anticipated to progress to meet the need for better cardiovascular technologies.

The expensive nature of atherectomy procedures and equipment limits accessibility in cost-sensitive regions.

Atherectomy is known to be costly both in terms of the procedures and the devices used in the processes, hence a major barrier to raising the Atherectomy Market as the best option. Atherectomy is a more complex technology, and hence, these devices are generally expensive, especially if they are packaged with some highly specialized features. These devices are normally applied only in highly specified healthcare organizations; their deployment calls for a huge outlay by the healthcare industry, impacting the growth of Atherectomy therapies. The equipment that is used in the operations is rather expensive, and besides, it requires a professional workforce to ensure the appropriate results, thus leading to a higher cost.

Besides the initial costs of the devices, the general approach has many related costs, for example, hospital stay, follow-up, and monitoring after the procedure, all adding to the cost implications for the Atherectomy Market. Low-income countries cannot afford to invest in expensive technologies such as atherectomy devices. In these regions, the healthcare system itself may not be developed, and such high costs can greatly reduce the availability of such a vital procedure, limiting the growth of Atherectomy therapies. This unavailability of better medical devices implies that there are a lot of patients in these areas who may not get the right treatment on time, hence such poor outcomes.

Untapped potential in developing regions with increasing healthcare infrastructure and awareness presents significant growth opportunities.

One of the most attractive opportunities identified in the Atherectomy Market is the increasing healthcare infrastructure in the developing region. Since these regions are developing their health care systems and increasing access to medical technologies, there will be an increase in the uptake of developed procedures like atherectomy. Atherectomy, a procedure of removing plaque from the arteries to manage PAD and CAD, could become a crucial component of the healthcare industry since those areas are experiencing growing cardiovascular ailment rates. As a result of the increased concern for cardiovascular diseases, patients and caregivers are increasingly embracing innovative therapies. Having these atherectomy procedures in these markets is helpful as it makes for better outcomes for the patient, as it helps them avoid complicated and risky surgeries; instead, they can opt for an atherectomy.

Also, local authorities as well as healthcare sectors may further encourage investments in relevant technologies in medical science, enhancing patients’ access to superior treatment. Since these regions are progressively being empowered to deal with complicated cardiovascular problems, then atherectomy might record significant improvement due to the rising number of patients requiring such treatments. The availability of locally affordable atherectomy devices may also positively influence its market uptake. Such dynamics put atherectomy at the center of the future and potential growth of cardiovascular solutions in developing countries.

Partnerships among key players for R&D and the introduction of next-generation devices can fuel market expansion.

Collaborative actions between different market players involved in the R&D of more advanced atherectomy devices will surely foster the growth of the Atherectomy Market. The integration of medical device manufacturing companies with research and university collaborations can help speed up the manufacturing of new products with the addition of lower risks of procedures. Such associations foster the provision of information and other assets that are necessary for developing advanced atherectomy equipment. Trends like improved precision, shorter recovery periods, and minimal incidents exist to drive ongoing improvements, which explains why R&D forms a very important element for value-determined Atherectomy Market device manufacturers to consider.

The next generation of atherectomy devices will have a safer profile, enhanced effectiveness in ablating plaque, and suitability for use in minimally invasive surgery. These advancements, as they are commercialized, hold the promise of changing the current management options for PAD and other related vascular diseases. They could also create devices that are easier to use, therefore making the atherectomy procedures accessible across many facilities. As precision medicine and patient-specific medical treatments are gaining ground, these developments can improve patients’ conditions substantially, and that is why the Atherectomy Market is expected to grow all over the world.

Industry Experts Opinion

“Atherectomy is an effective vessel prepping device but not all atherectomy devices are equal. The depth of vessel injury and residual narrowing vary considerably among atherectomy devices with significant implications on outcome.”

• Dr. Nicolas W. Shammas, MS-MD Division of Cardiology, University of Iowa.

Segment Analysis

Based on the product type, the Atherectomy Market is classified into directional atherectomy systems, rotational atherectomy systems, orbital atherectomy systems, and laser atherectomy systems. The rotational atherectomy systems segment is the largest in the Atherectomy Market. These systems are recognized for use in the treatment of atherosclerosis, especially in patients with severe and disordered atherosclerotic lesions of coronary arteries. Rotational atherectomy is used to modify the lumens of vessels that are heavily blocked up by calcified plaque and is therefore a valuable strategy for patients with highly stenotic blockages. The segment has maintained supremacy because of its proven clinical effectiveness in enhancing patients’ conditions and versatility in responding to several types of lesions. 

Based on the application, the Atherectomy Market is classified into cardiovascular disease, peripheral vascular disease (PVD), and, neurovascular disease. The cardiovascular disease (CVD) segment stands for the largest and most highly active segment within the Atherectomy Market. This is so mainly because of the increasing incidence of coronary artery disease, which is ranked among the top killers globally. Atherectomy devices are well known in the peripheral vascular and coronary interventions to remove the blockage from the arteries. The rising popularity of minimally invasive surgical procedures, coupled with the ever-growing pool of geriatric populations with relatively higher risk for cardiovascular diseases, increases the need for atherectomy in treating CVD.

Regional Analysis

North America is the largest region in the Atherectomy Market due to rising cardiovascular diseases and increased use of minimally invasive products and techniques. The Atherectomy Market in this region is fueled by the region’s strong healthcare infrastructure and development in atherectomy devices. Growth in the image of technology and improvement in the accuracy of devices used should also help drive the demand for atherectomy equipment in North America. Highlighted factors that could impact the growth and development of the atherectomy devices market in North America include substantial regulatory support for innovative medical devices and ascending perception of the atherectomy procedures among physicians, patients, and clients.

The Atherectomy Market is expanding at its fastest rate in the Asia Pacific region due to factors such as the increase in the aging population and enhancements in the global healthcare sector. That section also considers how only a few countries will be responsible for market growth, including China, Japan, and India, all due to medical technology and a growing elderly population. The increasing investment in healthcare facilities, the major market players, presence, and government-aimed improvement in cardiovascular care fuel the atherectomy procedures in the Asia Pacific region market. Agreements between domestic and foreign medical organizations to provide additional opportunities to improve the availability of an atherectomy procedure contribute even more to the Atherectomy Market growth.

Competitive Landscape

The leading players in the Atherectomy Market are Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Cardiovascular Systems Inc. (CSI), Koninklijke Philips N.V., and Terumo Corporation. These companies are at the forefront of CAD developers, new arrivals with products aimed at peripheral artery disease (PAD) and coronary artery disease (CAD). There are only two orbital atherectomy systems, the HawkOne Directional Atherectomy System of Medtronic and the Diamondback 360° Orbital Atherectomy System of Boston Scientific. A household name for the Rotablator Rotational Atherectomy System is Abbott Laboratories and Cardiovascular Systems Inc. (CSI) for their Diamondback 360° gadget.

Terumo and Philips use laser and rotating technologies to efficiently remove plaque during vascular intervention. Recent advances in the Atherectomy Market demonstrate the industry's dedication to innovation and expanded treatment options. Philips introduced its Nexcimer Laser System in 2021 with a focus on the treatment of coronary artery diseases through its’ superior technology to remove plaque. Thus, Cardiovascular Systems Inc. expanded its product portfolio by getting FDA clearance for using the Diamondback 360° Orbital Atherectomy System in interventional coronary procedures. Medtronic still retains the advantage in terms of growth through acquisition and partnership to enhance its catalog of products, although Boston Scientific has recently enhanced its atherectomy device range through the incorporation of the LithoVue™ Ureteral Laser Fiber.

Atherectomy Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Free Sample Report

Recent Developments:

• In November 2021, Royal Philips launched the Nexcimer Laser System, designed for both coronary and peripheral atherectomy procedures. This system offers plug-and-play simplicity, enhancing procedural efficiency and patient outcomes

• In October 2021, Becton, Dickinson, and Company (BD) announced that the U.S. Food and Drug Administration (FDA) had approved their 510(k) application for expanded indications for the Rotarex Atherectomy System. This approval allows for a broader range of applications in treating peripheral artery disease (PAD).

Report Coverage:

By Product Type

• Directional Atherectomy Systems
• Rotational Atherectomy Systems
• Orbital Atherectomy Systems
• Laser Atherectomy Systems

By Application

• Cardiovascular Disease
  • Coronary Artery Disease
• Peripheral Vascular Disease
  • Lower Extremity Disease
  • Upper Extremity Disease
• Neurovascular Disease

By Technology

• Mechanical Atherectomy
• Laser-Based Atherectomy
• Ultrasound-Based Atherectomy

By Mode of Operation

• Automated
• Manual

By End-User

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• Medtronic plc
• Boston Scientific Corporation
• Abbott Laboratories
• Cardiovascular Systems Inc.
• Koninklijke Philips N.V.
• Terumo Corporation
• B. Braun Melsungen AG
• Becton, Dickinson and Company
• Cardinal Health Inc.
• AngioDynamics Inc.
• Avinger Inc.
• Nipro Corporation
• Biomerics LLC
• Rex Medical
• Cordis

Frequently Asked Questions (FAQs)